TNF-α level affects etanercept clearance: TNF-α concentration as a new correction factor of allometric scaling to predict individual etanercept clearances in patients with ankylosing spondylitis-Reference-Cited by-同舟云学术

TNF-α level affects etanercept clearance: TNF-α concentration as a new correction factor of allometric scaling to predict individual etanercept clearances in patients with ankylosing spondylitis

Published:2018-03-11 Issue:7 Volume:45 Page:643-651
ISSN:0305-1870
Container-title:Clinical and Experimental Pharmacology and Physiology
language:en
Short-container-title:Clin Exp Pharmacol Physiol

Author:

Deng Yuwei¹,Hu Li²,Qiang Wei¹,Cheng Zeneng¹,Wang Lei¹³^ORCID,Wang Xiaoxia⁴

Affiliation:

1. Research Institute of Drug Metabolism and Pharmacokinetics; School of Pharmaceutical Sciences; Central South University; Changsha Hunan China

2. Department of Rheumatology; Shenzhen People's Hospital; Shenzhen Guangzhou China

3. School of Life Sciences; Central South University; Changsha Hunan China

4. Department of Rheumatology; The Second Hospital of Shanxi Medical University; Taiyuan Shanxi China

Funder

National Natural Science Foundation of China

Scientific Research Foundation for Postdoctoral of Central South University

China Postdoctoral Science Foundation

Publisher

Wiley

Subject

Physiology (medical),Pharmacology,Physiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1440-1681.12924/fullpdf

Reference33 articles.

1. Ankylosing spondylitis;Braun;Lancet,2007

2. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial;Braun;Lancet,2002

3. Enthesitis and ankylosis in spondyloarthropathy: what is the target of the immune response?;Braun;Ann Rheum Dis,2000

4. Epidemiology of spondyloarthritis in the People's Republic of China: review of the literature and commentary;Ng;Semin Arthritis Rheum,2007

5. The role of TNF-α in the pathogenesis of inflammation and joint destruction in rheumatoid arthritis (RA): a study using a human RA/SCID mouse chimera;Matsuno;Rheumatology,2002

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peri-Transplant Inflammation and Long-Term Diabetes Outcomes Were Not Impacted by Either Etanercept or Alpha-1-Antitrypsin Treatment in Islet Autotransplant Recipients;Transplant International;2024-01-31

2. Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate: observational study;Pediatric Rheumatology;2023-03-22

3. Etanercept for patients with juvenile idiopathic arthritis: drug levels and influence of concomitant methotrexate;2022-09-15

4. Predicting Loss of Efficacy after Non-Medical Switching: Correlation between Circulating TNF-α Levels and SB4 in Etanercept to SB4 Switchers and Naïve Patients with Rheumatic Disease;Journal of Personalized Medicine;2022-07-19

5. Etanercept Protected Against Cigarette Smoke Extract-Induced Inflammation and Apoptosis of Human Pulmonary Artery Endothelial Cells via Regulating TNFR1;International Journal of Chronic Obstructive Pulmonary Disease;2021-05